PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $454 | -99.5% | 18,857 | +50.9% | 0.00% | +300.0% |
| Q1 2022 | $92,000 | +15.0% | 12,500 | -12.2% | 0.00% | 0.0% |
| Q4 2021 | $80,000 | -56.8% | 14,237 | -50.7% | 0.00% | -50.0% |
| Q3 2021 | $185,000 | -47.7% | 28,887 | -31.1% | 0.00% | -50.0% |
| Q2 2021 | $354,000 | -38.2% | 41,939 | +3.3% | 0.00% | -73.3% |
| Q2 2020 | $573,000 | +258.1% | 40,608 | +133.2% | 0.02% | +66.7% |
| Q1 2020 | $160,000 | -91.1% | 17,411 | -85.5% | 0.01% | -73.5% |
| Q4 2019 | $1,794,000 | +1080.3% | 120,431 | +440.0% | 0.03% | +580.0% |
| Q3 2019 | $152,000 | – | 22,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |